Laxana-24 Soft Gel Capsule Capsule

About Laxana-24 Soft Gel Capsule

Laxana-24 Soft Gel Capsule is a laxative preparation containing the generic lubiprostone, supplied by Renata PLC. It comes as a soft gel capsule with a strength of 24 mcg and is used in certain constipation-related conditions in adults.

There are 4 brands of Lubiprostone listed in Bangladesh.

What is Laxana-24 Soft Gel Capsule?

Laxana-24 Soft Gel Capsule is a laxative-type medicine. Its active ingredient, lubiprostone, works locally in the intestine by activating chloride channels, which increases fluid secretion into the bowel and helps intestinal movement, supporting the passage of stool. It is prescribed for adults in specific situations such as irritable bowel syndrome with constipation, chronic idiopathic constipation, and opioid-induced constipation in chronic non-cancer pain. The capsule is taken by mouth, and the doctor decides the dose and how long it should be taken. It is not suitable for people with a known or suspected mechanical bowel obstruction. Ask your doctor or pharmacist if you have questions about whether it suits you.

Uses of Laxana-24 Soft Gel Capsule

Laxana-24 Soft Gel Capsule is used in adults for irritable bowel syndrome with constipation, chronic idiopathic constipation, and opioid-induced constipation in people with chronic non-cancer pain. It is a laxative preparation that helps relieve constipation by increasing fluid secretion and movement in the intestine. Only a doctor can confirm whether it is appropriate for your situation.

How to use Laxana-24 Soft Gel Capsule

Take Laxana-24 Soft Gel Capsule by mouth as your doctor directs. The dose and course are decided by the doctor and are not the same for every condition, so follow the prescription exactly and do not change it yourself. Taking it with food and water may help reduce nausea. If you miss a dose or are unsure how to take it, ask your doctor or pharmacist rather than guessing.

Side effects of Laxana-24 Soft Gel Capsule

Common side effects include diarrhea, nausea, stomach pain, and a full, bloated or swollen feeling in the abdomen. Some people may feel short of breath. Diarrhea can sometimes be troublesome, so tell your doctor if it is severe or does not settle. Seek medical advice promptly if you have troublesome or persistent symptoms, or if anything worries you while taking this medicine.

Safety and precautions

Do not take Laxana-24 Soft Gel Capsule if you have or may have a mechanical bowel obstruction; the doctor will assess this before starting treatment. It should not be prescribed to people with severe diarrhea. Food taken with the capsule may ease nausea. It is classed as pregnancy category C, and it is not known whether it passes into breast milk, so speak to your doctor before use if you are pregnant, planning pregnancy or breastfeeding; breastfed babies should be watched for diarrhea. Tell your doctor about liver problems, other medicines, particularly certain opioid painkillers, and any allergies before starting.

Frequently asked questions

Is Laxana-24 Soft Gel Capsule safe during pregnancy or breastfeeding?

It is classed as pregnancy category C, and it is not known whether it passes into breast milk. Do not start it on your own if you are pregnant, planning pregnancy or breastfeeding; ask your doctor, who will weigh the benefits and risks for you and your baby.

What is Laxana-24 Soft Gel Capsule used for and what kind of medicine is it?

It is a laxative preparation containing lubiprostone, used in adults for irritable bowel syndrome with constipation, chronic idiopathic constipation, and opioid-induced constipation in chronic non-cancer pain. Your doctor will confirm whether it is suitable for your condition.

What do the dosage form and strength of Laxana-24 Soft Gel Capsule mean?

It is a soft gel capsule, a small capsule that is swallowed whole. The strength is 24 mcg, meaning each capsule contains 24 micrograms of lubiprostone. The doctor decides the dose and course; do not change them yourself.

Who should check with a doctor before using Laxana-24 Soft Gel Capsule?

Anyone with a known or suspected bowel obstruction, severe diarrhea, liver problems, or who is pregnant or breastfeeding should speak to a doctor first. Also tell your doctor about other medicines you take, especially certain opioid painkillers, before starting.

Indications

Lubiprostone is indicated in:
  • Irritable Bowel Syndrome with Constipation (IBS-C).
  • Chronic Idiopathic Constipation (CIC) in adults.
  • Opioid-Induced Constipation (OIC) in adult patients with chronic, non-cancer pain.

Pharmacology

Lubiprostone is a locally-acting chloride-channel activator that increases intestinal secretion. In doing so, it increases intestinal motility, thus aiding the passage of stool and relieve the symptoms associated with chronic idiopathic constipation.

Lubiprostone acts by specifically activating ClC-2 chloride channels, which is a normal constituent of the apical membrane of the human intestine, in a protein kinase A action independent fashion. Activation of ClC-2 chloride channels causes an efflux of chloride ions into the lumen, which in turn leads to an efflux of sodium ions through a paracellular pathway to maintain isoelectric neutrality. As a result, water follows sodium into the lumen in order to maintain isotonic equilibrium, thereby increasing intestinal fluid secretion. By increasing intestinal fluid secretion, lubiprostone increases motility in the intestine, thereby increasing the passage of stool and alleviating symptoms associated with chronic idiopathic constipation. Activation of ClC-2 chloride channels may also stimulate the recovery of muscosal barrier function by restoring tight junction protein complexes in the intestine. Patch clamp cell studies in human cell lines have indicated that the majority of the beneficial biological activity of lubiprostone and its metabolites is observed only on the apical (luminal) portion of the gastrointestinal epithelium.

Dosage & Administration

Irritable Bowel Syndrome with Constipation: The recommended dose is 8 mcg twice daily orally with food and water.

Dosage in patients with hepatic impairment: Dosage adjustment is not required for patients with moderately impaired hepatic function. For patients with severely impaired hepatic function, the recommended starting dose is 8 mcg once daily. If tolerated then dose can be increased to 8 mcg twice 

Chronic Idiopathic Constipation and Opioid-induced Constipation: The recommended dose is 24 mcg twice daily orally with food and water. 

Dosage in patients with hepatic impairment: For patients with moderately impaired hepatic function, the recommended starting dose is 16 mcg twice daily. For patients with severely impaired hepatic function, the recommended starting dose is 8 mcg twice daily.

Interaction

There is a possibility of a dose-dependent decrease in the efficacy of Lubiprostone in patients using diphenylheptane opioids.

Contraindications

Lubiprostone is contraindicated in patients with known or suspected mechanical gastrointestinal obstruction.

Side Effects

Diarrhea, full or bloated feeling or pressure in the stomach, nausea, stomach pain, swelling of abdominal or stomach area, Dyspnea

Pregnancy & Lactation

Pregnancy category C. It is not known whether lubiprostone is excreted in human milk. Because lubiprostone increases fluid secretion in the intestine and intestinal motility, human milk-fed infants should be monitored for diarrhea. Caution should be exercised when Lubiprostone is administered to a nursing woman.

Precautions & Warnings

Nausea: Patients taking Lubiprostone may experience nausea. Concomitant administration of food with Lubiprostone may reduce symptoms of nausea.

Diarrhea: Lubistone should not be prescribed to patients that have severe diarrhea.

Bowel Obstruction: In patients with symptoms suggestive of mechanical gastrointestinal obstruction, perform a thorough evaluation to confirm the absence of an obstruction prior to initiating therapy with Lubiprostone.

Overdose Effects

Adverse reactions due to overdose may include: nausea, diarrhea, vomiting, dizziness, headache, abdominal pain, flushing/hot flash, retching, dyspnea, pallor, stomach discomfort, anorexia, asthenia , chest discomfort, dry mouth, hyperhidrosis , and syncope.

Storage Conditions

Store between 15-30° C.

Alternative brands of Lubiprostone

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.